Krebsforum Lazarus

[*QUOTE*]
------------------------------------------------
My Medical Choice
By ANGELINA JOLIE
Published: May 14, 2013
LOS ANGELES

MY MOTHER fought cancer for almost a decade and died at 56. She held out long enough to meet the first of her grandchildren and to hold them in her arms. But my other children will never have the chance to know her and experience how loving and gracious she was.
------------------------------------------------
[*/QUOTE*]

more:
http://www.nytimes.com/2013/05/14/opinio…cal-choice.html

[*QUOTE*]
-------------------------------------------
Treating cancer with physics
[...]
Just last week, Advanced Oncotherapy, a British firm purchased a small spin off company of CERN. The primary aim of this company is to use proton beam therapy (PBT) to destroy cancerous cells. As opposed to conventional radiotherapy this new technique uses protons to destroy the cancer cells as opposed to X-rays, the benefit of this is that protons can be focussed more accurately.

This means that it can target the cancerous cells without damaging the surrounding healthy tissue, this is of particular importance for areas of the body such as the brain and the spine, where damaging surrounding tissue can lead to paralysis and even death.
-------------------------------------------
[*/QUOTE*]

more:
http://www.nouse.co.uk/2013/05/07/treati…r-with-physics/

Kommt gleich in dradio:

28.04.2013 · 16:30 Uhr

[*QUOTE*]
----------------------------
Es ist ein einmaliger Vorgang in der deutschen Medizingeschichte: In der Universitätsklinik Kiel wird derzeit eines der weltweit modernsten medizintechnischen Geräte zur Krebstherapie wieder abgerissen - noch bevor auch nur ein Krebspatient behandelt werden konnte und obwohl die Anlage zur Erzeugung von Protonenstrahlen fast betriebsbereit war. Doch Hersteller Siemens hatte entdeckt, dass der angestrebte Gewinn nicht zu erreichen war. Der Konzern entschied radikal und schnell: Abriss. Da nützte es auch nichts, dass die Anlage Hoffnung für viele Patienten bedeutete und neue Möglichkeiten der Krebstherapie eröffnet hätte.
----------------------------
[*/QUOTE*]

mehr:
http://www.dradio.de/dlf/programmtipp/wib/2074238/

[*QUOTE*]
-------------------------------------------------
Radioaktive Trojaner im Kampf gegen Metastasen
Kurt de Swaaf, 23. April 2013, 17:22

Listerien gelten normalerweise als gefährliche Erreger - Die Bakterien können aber auch genutzt werden, um eine Art nukleare Sprengköpfe in Krebszellen einzuschleusen

So mancher nennt ihn den schleichenden Tod. Das pankreatische duktale Adenokarzinom, besser bekannt als Bauchspeicheldrüsenkrebs, ist eine besonders heimtückische Krankheit. Die Geschwüre bilden bereits Metastasen, bevor sie aufgrund spezifischer Symptome entdeckt werden können. Die Tochtertumoren setzen sich vor allem in der Leber fest. Sie widerstehen klassischen Strahlen- und Chemotherapien und wachsen aggressiv weiter. Nur vier Prozent der Patienten überlebt länger als vier Jahre.
-------------------------------------------------
[*/QUOTE*]

mehr:
http://derstandard.at/1363708962117/Radi…egen-Metastasen



[*QUOTE*]
-------------------------------------------------
Public release date: 22-Apr-2013
Contact: Deirdre Branley
sciencenews@einstein.yu.edu
Tel: 001-718-430-3101

Albert Einstein College of Medicine
Radioactive bacteria targets metastatic pancreatic cancer
Novel approach using Listeria bacteria shows promise against a deadly disease

VIDEO: Claudia Gravekamp, Ph.D., discusses her research on a new therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. Dr. Gravekamp is...
Click here for more information.

April 22, 2013 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The experimental treatment dramatically decreased the number of metastases (cancers that have spread to other parts of the body) in a mouse model of highly aggressive pancreatic cancer without harming healthy tissue....[Weiterlesen]

Prof. Edzard Ernst berichtet über eine koreanische Studie, bei der untersucht wurde, wie gut "alternative" Methoden Krebskranken nutzen. Das Ergebnis ist verheerend:

[*QUOTE*]
------------------------------------
Cancer patients who use alternative medicine die sooner

The authors conclude that “CAM did not provide any definite survival benefit, CAM users reported clinically significant worse HRQOLs.”
------------------------------------
[*/QUOTE*]

mehr:
http://edzardernst.com/2013/04/cancer-pa…ine-die-sooner/



Der abstract der Studie:

[*QUOTE*]
------------------------------------
Ann Oncol. 2013 Feb;24(2):489-94. doi: 10.1093/annonc/mds469. Epub 2012 Oct 30.

Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study.

Yun YH, Lee MK, Park SM, Kim YA, Lee WJ, Lee KS, Choi JS, Jung KH, Do YR, Kim SY, Heo DS, Kim HT, Park SR.
Source

Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul, Korea. awyun@snu.ac.kr

Abstract

BACKGROUND:

We evaluated whether complementary and alternative medicine (CAM) use influenced outcomes [survival and health-related quality of life (HRQOL)] of cancer patients whose condition had just been judged terminal.

PATIENTS AND METHODS:

From July 2005 to October 2006, we conducted a prospective cohort study of 481 terminally ill cancer patients at 11 university hospitals and the National Cancer Center in Korea. We assessed how the use of CAM affected HRQOL and survival.

RESULTS:

In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased cases. On multivariate analyses, CAM users did not have better survival compared with nonusers [adjusted hazard ratio (aHR), 0.91; 95% confidence interval (CI) 0.74-1.10]. Among mind-body interventions, prayer showed significantly worse survival (aHR, 1.56; 95% CI, 1.00-2.43). Clinically, CAM users reported significantly worse...[Weiterlesen]